Erlocip 100 Tablet is utilized in the therapy of non-small cell cellular breakdown in the lungs and pancreatic cancer. Erlocip 100 Tablet is an enemy of disease medicine. Epidermal growth factorreceptors (EGFR) are communicated on the cellular breakdown in the lungs cell surfaces that regulate their development. Erlocip 100 Mg works by restricting the substance courier, EGFR, henceforth, restrains the cancer flagging pathways intervened by EGFR. This is the way it confines further development of the cancer cells.